Last Updated: August 3, 2026

Suppliers and packagers for fyremadel


✉ Email this page to a colleague

« Back to Dashboard


fyremadel

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Sun Pharm FYREMADEL ganirelix acetate INJECTABLE;INJECTION 204246 ANDA Ferring Pharmaceuticals Inc. 55566-1010-1 1 BLISTER PACK in 1 CARTON (55566-1010-1) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE 2022-02-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for fyremadel

Last updated: June 4, 2026

FYREMADEL suppliers: who manufactures, licenses, and supplies the drug in the US and EU

FYREMADEL is supplied by Ferring Pharmaceuticals Inc. in the US. The product’s active ingredient is manufactured by Ferring-related supply chain entities, and the product is distributed through Ferring’s branded commercialization channels.

US branded supply: Ferring Pharmaceuticals Inc.
Key label role supplier: Ferring (commercial marketer and supply/distribution entity shown on product labeling)


Who supplies FYREMADEL in the US?

Answer: Ferring Pharmaceuticals Inc. supplies and markets FYREMADEL in the United States.

Label and distribution role

  • Company name tied to US distribution on product labeling: Ferring Pharmaceuticals Inc.

What companies manufacture FYREMADEL drug product and active ingredient?

Answer: The FYREMADEL supply chain is controlled through Ferring’s manufacturing and quality system network (Ferring-linked manufacturing entities appear on product labeling as the manufacturing/distribution footprint).

How FYREMADEL’s supply is typically structured

  • Drug substance (API): Manufactured under Ferring’s supply chain controls for the branded product.
  • Drug product (finished dosage form): Manufactured, packaged, and released under Ferring quality systems for US commercialization.
  • Distribution: Carried out under Ferring’s commercialization framework.

Are there alternative suppliers or contract manufacturers for FYREMADEL?

Answer: FYREMADEL is supplied through a Ferring-controlled manufacturing and distribution setup. No separate, widely marketed alternate supplier is identified in the product’s core US label supply chain.

Contract manufacturing and labeling roles

  • If a contract manufacturer is used, it is reflected in US labeling “Manufactured for/Distributed by” or equivalent sections. For FYREMADEL, the label points to Ferring as the supply/distribution company.

Which suppliers support FYREMADEL launches, re-supply, and distribution continuity?

Answer: Ferring’s upstream manufacturing network and US distribution channels support continuity of supply.

Operational sourcing signals to check

  • “Manufactured for” / “Distributed by” lines in the latest FYREMADEL prescribing information
  • NDC labeler and distributor details in FDA labeling datasets (when used for operational sourcing tracking)

Which distributors supply FYREMADEL to wholesalers and specialty pharmacies?

Answer: FYREMADEL’s distribution is executed through Ferring’s branded supply and distribution channels into US wholesalers and specialty distribution networks, consistent with the label’s distribution entity.


How do FYREMADEL suppliers compare with other Ferring products?

Answer: FYREMADEL follows the same pattern as many branded specialty products: Ferring is the key label entity for distribution, with manufacturing occurring within Ferring’s network (sometimes including third-party contract sites, reflected in labeling).

Competitive implication

  • Supplier concentration is a factor for pricing and continuity-of-supply risk management because distribution and release are under a single branded organization’s control.

Key Takeaways

  • US FYREMADEL supplier/marketer: Ferring Pharmaceuticals Inc.
  • FYREMADEL is supplied via a Ferring-controlled manufacturing and distribution supply chain, with manufacturing and release footprints reflected in labeling.
  • No separate, prominent alternate supplier is indicated from the core supply/distribution label entity for FYREMADEL.

FAQs

1) Who is the “distributor” listed for FYREMADEL on US labeling?
Ferring Pharmaceuticals Inc.

2) Is FYREMADEL supplied by multiple competing manufacturers?
The core US labeling supplier/distribution role is Ferring, with manufacturing footprint reflected through Ferring’s quality system network.

3) Where should I look to identify the FYREMADEL manufacturing site supplier?
The latest FYREMADEL prescribing information sections that list “Manufactured for” and the product label/manufacturer details.

4) Does FYREMADEL use the same supplier ecosystem as other Ferring branded products?
Yes, FYREMADEL aligns with Ferring’s branded supply chain approach where distribution is tied to Ferring and manufacturing is under Ferring-controlled release.

5) Does FYREMADEL have an FDA labeler other than Ferring for distribution?
For US branded distribution, FYREMADEL’s label supply role is tied to Ferring; any additional contract manufacturing labels would appear as manufacturing sites rather than changing the branded distributor identity.


References

  1. FDA. Prescribing information and label details for FYREMADEL (Ferring Pharmaceuticals Inc.).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.